Eiger Announces FDA Fast Track Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection

PALO ALTO, Calif., July 27, 2017 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for rare diseases, today announced that the U.S. Food and D... Biopharmaceuticals, FDA Eiger BioPharmaceuticals, Hepatitis Delta Virus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news